×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: generics | Mylan | Abbott | stock

Mylan to Buy Abbott's Non-US Specialty, Branded Generics Assets

Monday, 14 July 2014 06:55 AM

Generic drugmaker Mylan Inc. said it would buy Abbott Laboratories' specialty and branded generics business outside the United States in an all-stock transaction valued at about $5.3 billion.

Abbott will receive 105 million shares of the combined company.

© 2021 Thomson/Reuters. All rights reserved.


InvestingAnalysis
Generic drugmaker Mylan Inc. said it would buy Abbott Laboratories' specialty and branded generics business outside the United States in an all-stock transaction valued at about $5.3 billion.
generics, Mylan, Abbott, stock
38
2014-55-14
Monday, 14 July 2014 06:55 AM
Newsmax Media, Inc.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved